MILESTONE SCIENTIFIC INC (MLSS) Stock Overview
USA - NYSEARCA:MLSS - US59935P2092 - Common Stock
MLSS Key Statistics, Chart & Performance
The current stock price of MLSS is 0.4454 USD. In the past month the price decreased by -9.25%. In the past year, price decreased by -42.9%.
MLSS Latest News, Press Relases and Analysis
MLSS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.56 | 221.98B | ||
| ISRG | INTUITIVE SURGICAL INC | 57.48 | 165.88B | ||
| BSX | BOSTON SCIENTIFIC CORP | 35.3 | 148.03B | ||
| SYK | STRYKER CORP | 29.55 | 145.19B | ||
| MDT | MEDTRONIC PLC | 17.33 | 122.92B | ||
| BDX | BECTON DICKINSON AND CO | 13.25 | 54.18B | ||
| IDXX | IDEXX LABORATORIES INC | 53.05 | 50.97B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.58 | 44.63B | ||
| RMD | RESMED INC | 28.09 | 39.14B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.33 | 34.74B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.9 | 27.34B | ||
| DXCM | DEXCOM INC | 41.03 | 27.35B |
Related stock screener links
About MLSS
Company Profile
Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. The company is headquartered in Livingston, New Jersey and currently employs 17 full-time employees. The firm patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The firm operates through two segments: dental and medical. The firm has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.
Company Info
MILESTONE SCIENTIFIC INC
220 S Orange Ave
Livingston NEW JERSEY 07068 US
CEO: Leonard Osser
Employees: 17
Phone: 19735352717
MILESTONE SCIENTIFIC INC / MLSS FAQ
What is the stock price of MILESTONE SCIENTIFIC INC today?
The current stock price of MLSS is 0.4454 USD. The price increased by 2.41% in the last trading session.
What is the ticker symbol for MILESTONE SCIENTIFIC INC stock?
The exchange symbol of MILESTONE SCIENTIFIC INC is MLSS and it is listed on the NYSE Arca exchange.
On which exchange is MLSS stock listed?
MLSS stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for MILESTONE SCIENTIFIC INC stock?
8 analysts have analysed MLSS and the average price target is 1.66 USD. This implies a price increase of 272.14% is expected in the next year compared to the current price of 0.4454. Check the MILESTONE SCIENTIFIC INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MILESTONE SCIENTIFIC INC worth?
MILESTONE SCIENTIFIC INC (MLSS) has a market capitalization of 34.99M USD. This makes MLSS a Nano Cap stock.
How many employees does MILESTONE SCIENTIFIC INC have?
MILESTONE SCIENTIFIC INC (MLSS) currently has 17 employees.
What are the support and resistance levels for MILESTONE SCIENTIFIC INC (MLSS) stock?
MILESTONE SCIENTIFIC INC (MLSS) has a support level at 0.43 and a resistance level at 0.51. Check the full technical report for a detailed analysis of MLSS support and resistance levels.
Is MILESTONE SCIENTIFIC INC (MLSS) expected to grow?
The Revenue of MILESTONE SCIENTIFIC INC (MLSS) is expected to grow by 6.02% in the next year. Check the estimates tab for more information on the MLSS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MILESTONE SCIENTIFIC INC (MLSS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MLSS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MLSS, evaluating the profitability, health, valuation and growth aspects
- MILESTONE SCIENTIFIC INC (MLSS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MILESTONE SCIENTIFIC INC (MLSS) Sales and EPS estimates to see what analysts future expectations are.
- MILESTONE SCIENTIFIC INC (MLSS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MILESTONE SCIENTIFIC INC (MLSS) Insider and Institutional Ownership to learn about the owners and their transactions.
- MILESTONE SCIENTIFIC INC (MLSS) Stock Chart to make your own analysis
- MILESTONE SCIENTIFIC INC (MLSS) Latest news and press-releases to stay up to date.
Does MILESTONE SCIENTIFIC INC (MLSS) stock pay dividends?
MLSS does not pay a dividend.
When does MILESTONE SCIENTIFIC INC (MLSS) report earnings?
MILESTONE SCIENTIFIC INC (MLSS) will report earnings on 2025-11-12.
What is the Price/Earnings (PE) ratio of MILESTONE SCIENTIFIC INC (MLSS)?
MILESTONE SCIENTIFIC INC (MLSS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.09).
What is the Short Interest ratio of MILESTONE SCIENTIFIC INC (MLSS) stock?
The outstanding short interest for MILESTONE SCIENTIFIC INC (MLSS) is 0.21% of its float. Check the ownership tab for more information on the MLSS short interest.
MLSS Technical Analysis
MLSS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MLSS. MLSS has a bad profitability rating. Also its financial health evaluation is rather negative.
MLSS Financial Highlights
Over the last trailing twelve months MLSS reported a non-GAAP Earnings per Share(EPS) of -0.09. The EPS decreased by -40.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -86.63% | ||
| ROE | -208.8% | ||
| Debt/Equity | 0.25 |
MLSS Forecast & Estimates
8 analysts have analysed MLSS and the average price target is 1.66 USD. This implies a price increase of 272.14% is expected in the next year compared to the current price of 0.4454.
For the next year, analysts expect an EPS growth of 20.67% and a revenue growth 6.02% for MLSS